ABBV-075 exhibited strong inhibitory effects on the growth of SCLC cells by activating caspase-3/7, upregulating the proapoptotic protein BIM, and downregulating both BCL-2 and BCL-XL. This evidence concerns the gene BCL2 and small cell lung carcinoma.